SAS Output

10-APR-2021 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1613-mCRC, Adv/Met, TP vs CETIRI 1 Y 0 Screening 130 218 39 25 13 3 1 11/27/2017 292 115
            218 39 25 13 3 1      
 
    2 Y 1 Trastuzumab + Pertuzumab 130 21 6 6 3 2 0 11/27/2017    
        2 Cetuximab + Irinotecan   24 6 5 5 1 0      
            45 12 11 8 3 0      
 
    3 Y 3 Crossover: Trastuz + Pertuz 130 13 2 1 1 1 0 11/27/2017    
            13 2 1 1 1 0      
 
  S1922-Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect 1 Y 1 Ramucirumab + Paclitaxel 94 4 4 4 0 0 0 06/01/2020 148 54
        2 FOLFIRI   4 4 2 1 0 0      
            8 8 6 1 0 0      
 
  S2001-Rando II, Mets Pancreas , BRCA1/2, Comb Chemo 1 Y 1 Olaparib + Pembrolizumab 88 1 1 1 1 0 0 02/22/2021 72 36
            1 1 1 1 0 0      
 
Yes A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC 1 E Total Registrations   44 18 12 3 0 0 03/23/2018 354 179
            44 18 12 3 0 0      
 
  A021806-Pancreas, Perioperative vs Adjuvant Chemo 0 E Total Registrations   4 4 3 2 0 0 10/08/2020 206 104
            4 4 3 2 0 0      
 
    1 E Total Registrations   3 3 3 1 0 0 10/08/2020    
            3 3 3 1 0 0      
 
  EA2186-PANC, mets, Gem+Abraxane vs 5-FU+LV+Nal-IRI 1 E Total Registrations   6 6 6 3 1 0 11/18/2020 19 18
            6 6 6 3 1 0      
 
No A021602-PANC, Adv PNET Blinded Cabozantinib v Placebo 1 E Total Registrations   10 4 2 0 0 0 06/11/2019 241 96
            10 4 2 0 0 0      
 
  A021703-COLON, Adv/Met, Chemo + Std v High dose V-D3 1 E Total Registrations   9 7 5 2 0 0 03/04/2020 268 144
            9 7 5 2 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   6 1 1 0 0 0 07/14/2016 169 89
            6 1 1 0 0 0      
 
  EA2165-Anal, Stg II-III, Nivolumab after CMT 1 E Total Registrations   29 9 5 1 0 0 10/09/2018 274 138
            29 9 5 1 0 0      
 
    2 E Total Registrations   24 9 5 1 0 0 10/09/2018    
            24 9 5 1 0 0      
 
  EA2187-ICC, Carboplatin+Paclitaxel +/- Pevonedistat 1 E Total Registrations   7 7 7 5 3 0 12/09/2020 25 9
            7 7 7 5 3 0      
 
  NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy 1 T Total Registrations   14 1 0 0 0 0 04/18/2018 273 126
            14 1 0 0 0 0      
 
  NRGGI005-COLON,Stg IIA, ctDNA in Adjuvant Chemotherapy 1 T Total Registrations   3 3 1 0 0 0 07/06/2020 336 146
            3 3 1 0 0 0